Healthcare Careers
  • Search Jobs
  • For Employers
    • Learn More
    • Pricing
    • Post a Job
  • Sign in
  • Sign up
  • Search Jobs
  • For Employers
    • Learn More
    • Pricing
    • Post a Job

2 lead coder jobs found

Refine Search
Current Search
(COPC) Certified Ophthalmology Coder lead coder California
Refine by Current Certifications
(CPC) Certified Professional Coder  (37) (CPB) Certified Professional Biller  (5) (CRC) Certified Risk Adjustment Coder  (2) (COC) Certified Outpatient Coder  (1) (CCC) Certified Cardiology Coder  (1) (CGSC) Certified General Surgery Coder  (1)
(COSC) Certified Orthopedic Surgery Coder  (1)
More
Refine by City
San Francisco  (2)
AB
Associate Director, Field Medical Director Ophthalmology North America West
Annexon Biosciences San Francisco, CA, USA
Associate Director, Field Medical Director Ophthalmology North America West At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of-concept data in Guillain-Barr syndrome, Huntington's disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you'll be part of a team committed to making an impact together. We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're...

Feb 15, 2026
AB
Associate Director, Field Medical Director - Ophthalmology North America West
Annexon Biosciences San Francisco, CA, USA
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington's disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you'll be part of a team committed to making an impact together. For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol...

Feb 05, 2026
  • AAPC
  • Contact
  • About Us
  • Terms & Conditions
  • Employer
  • Post a Job
  • Pricing
  • Sign in
  • Job Seeker
  • Find Jobs
  • AAPC Resume Writing Service
  • Sign in
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn